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Background: Calcium (Ca2+) and vitamin D (VitD) play an important role in child health. We evaluated the daily
intake of Ca2+ and VitD in healthy children. Moreover, we demonstrate the efficacy of Ca2+ and VitD
supplementation.
Methods: Daily Ca2 + and VitD intake was evaluated in consecutive healthy children through a validated
questionnaire. Subjects with <70% of dietary reference intakes (DRIs) of Ca2+ and VitD were invited to participate in a
prospective randomized trial with 2 groups of nutritional intervention: Group 1, dietary counseling aiming to optimize
daily Ca2+ and VitD intake plus administration of a commercially available Ca2 + and VitD supplementation product;
Group 2, dietary counseling alone. At the enrollment (T0) and after 4 months (T1) serum 25(OH) Vitamin D levels were
assessed.
Results: We evaluated 150 healthy children (male 50%, mean age 10 years); at baseline a low VitD intake was
observed in all subjects (median 0.79 μg/die, IQR 1.78; range 0.01-5.02); this condition was associated with
Ca2+ intake <70% of the DRIs in 82 subjects (55%). At baseline serum 25(OH)D levels were low (<30 ng/ml) in all
study subjects and after 4 months of nutritional intervention, a normalization of serum 25(OH)D levels (≥30 ng/ml)
was observed in all children in Group 1 and in only one subject in Group 2 [Group 1: T1 33.8 ng/ml (IQR 2.5)
vs Group 2: T1 24.5 ng/ml (IQR 5.2), p <0.001].
Conclusions: Adequate Ca2+ and VitD intakes are difficult to obtain through dietary counseling alone in pediatric
subjects. Oral supplementation with of Ca2+ and VitD is a reliable strategy to prevent this condition.
Trial registration: The study was registered in Clinical Trials Protocol Registration System (ID number:
NCT01638494).
Keywords: 25-hydroxyvitamin D, Dietary counseling, Pediatrics, Ca2+ intake, VitD intake, Bone metabolism,
Nutritional intervention, Vitamin D supplement, Vitamin D deficiencyBackground
Adequate dietary intake of calcium (Ca2+) and vitamin D
(VitD) in children is important to guarantee normal
bone mineralization and for rickets prevention. Bone is
the main store of Ca2+, it is a reserve for the homeostasis
of serum Ca2+concentration, which varies within narrow* Correspondence: berni@unina.it
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reproduction in any medium, provided the orlimits around 2.5 mmol/L (10 mg/dL). Apart from its
main structural role, Ca2+ is also important in coagula-
tion cascade, in neuromuscular excitability and contrac-
tion, in enzyme hormones and growth factors activity,
in secretion of hormones and in cell growth and differ-
entiation [1]. Dietary Recommended Intake (DRI) for
Ca2+ is 700 mg/day for children aged 1–3 years, 1000
mg/day for children aged 4–8 years, and 1300 mg/day
for children aged 9–10 year and adolescents [2].
The metabolism of Ca2+ closely depends on VitD,
parathormone and calcitonin levels. Vitamin D stimu-
lates intestinal absorption of Ca2+ and phosphorus, andl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mineralization of the skeleton [3]. Apart for the funda-
mental role in bone and Ca2+ homeostasis, recent evi-
dences suggest that VitD, through its active form, has
pleiotropic roles in both innate and adaptive immunity.
A correct intake of VitD has been implicated in the pre-
vention of a number of conditions including auto-
immunity, atopic disorders, certain forms of cancer,
chronic hepatitis C, obesity and cardiovascular diseases
[4-13]. According with these findings the American
Academy of Pediatrics (AAP) changed the recommenda-
tions on VitD intake. The new recommended daily in-
take is 400 IU for infants, children and adolescents [2].
Unfortunately, despite this recommandation, studies
have reported a high rate of VitD insufficiency in the
pediatric age in Western countries [14,15]. These results
have a multi-factorial origin, among these the insuffi-
cient intake related to dietary habits of children and ado-
lescents is considered to be the most important factor.
Moreover the efficacy and practicability of a dietary
intervention aiming to normalize Ca2+ and VitD intake
is still largely unknown. We investigated Ca2 + and VitD
intake and the efficacy and applicability of a nutritional
intervention to aimed optimize Ca2+ and VitD intake in
a population of healthy children.
Methods
Study design and population
The study protocol was approved by the Ethics Commit-
tee of the Medical School of the University of Naples
"Federico II”. Otherwise healthy subjects (male and fe-
male, age range 3–17 years) consecutively observed as
outpatients at our Department for routine clinical exam-
ination because vaccination program were considered
eligible for the study. Exclusion criteria were: malnutri-
tion (defined as a weight/height ratio <5° centile); pres-
ence of chronic systemic diseases (celiac disease,
inflammatory bowel disease, food allergy, cystic fibrosis,
malignancy, immunodeficiency, tuberculosis, genetic-
metabolic disease, primitive bone disease, diabetes and
endocrine disorder); use of systemic steroids in the pre-
vious 3 months. We excluded from the study even
people who did not speak Italian properly and were not
able to understand the Italian language and households
non-resident in the Campania region. At the enrollment,
information about the aim of the study were given to
children’s parents and a written consent was collected
from those who agreed to participate. The study was
registered in Clinical Trials Protocol Registration System
(ID number: NCT01638494).
Intervention and data collection
At the enrollment, data regarding auxological parame-
ters and general clinical conditions were assessed by 3pediatricians unaware of the study aims. Then, all en-
rolled subjects were carefully evaluated by registered die-
ticians, with a wide experience in pediatric nutrition,
assessing the dietary Ca2+ and VitD intake by a 3-day
diary. The parents received written and oral instructions
on how to keep the diary, recording everything that the
child ate or drank and noting the quantities using house-
hold measures. Picture models of sizes of food that
helped parents to estimate portion sizes were also pro-
vided. Further assumptions of Ca2+ and/or VitD or forti-
fied foods were also registered. All data were recorded in
a specific clinical chart and were analyzed using a spe-
cific software based on the Italian food composition ta-
bles (Winfood, Medimatica SRL, Martinsicuro, Teramo,
Italy). All subjects with less than 70% of Ca2+ and VitD
DRIs were invited to participate in the study. Using a
computer generated list, these subjects were randomly
allocated into one of 2 groups of nutritional interven-
tion: Group 1, receiving dietary counseling to improve
daily Ca2+ and VitD intake, plus administration of a
commercially available Ca2+ and VitD supplementation
product (Colecalcium Humana®, Milan, Italy; syrup: 10
ml/daily, containing 400 mg of Ca2+ and 400 IU of
VitD); and Group 2, receiving dietary counseling alone.
The dietary counseling, focused on feeding behaviors,
selection pleasant food and children’s preferences was
provided by dietitians unaware of the study aims. The
dietitians gave information to the parents on how to im-
prove the consumption of foods rich in Ca2+ and VitD
according to DRIs, such as cod liver oil, salmon, mack-
erel, tuna fish, sardines, milk, cereal, egg, liver beef,
cheese. No nutritional support products were prescribed
in children enrolled in Group 2. In Group 1, Ca2+ and
VitD supplementation product was given directly to the
parents/tutors of the enrolled child. Each parent/tutor
received eight bottles of the study product (150 ml/each)
for the entire duration of the study. The families were
asked to return the bottles at the end of the study period
to check the adherence to the treatment. For all study
subjects, data regarding demographic characteristics,
auxologic parameters, outdoor sport activities, dietary
Ca2+ and VitD intake, and adherence to the assigned
treatment were collected in a specific clinical chart. At
the enrolment (T0) and after 4 months of nutritional
intervention (T1), all subjects underwent to a blood
sampling (6 ml) to determine serum Ca2+ and 25 hy-
droxy vitamin D (25(OH)D) levels. For each study sub-
ject blood samples were obtained in the same season.
Serum 25(OH)D levels were measured by a quantitative
electrochemiluminescent method (Roche Elecsys assay,
Roche Diagnostics SPA, Monza, Italy) and expressed as
ng/ml. Serum Ca2+ concentration was measured using a
spectrophotometer with a λ of 570 nm, and expressed as
mg/dl. Serum Ca2+ results were compared with
Table 1 Baseline main demographic and clinic characteristics
of subjects enrolled in the randomized trial
Group 1 Group 2
(dietary counseling
plus Ca2+ and Vitamin D
supplementation)
(dietary
counseling only)
n=10 n=10
Age (years) 13.3 11.4
(9.9-16.6) (8.5-14.1)
Male 4 6
Weight (kg) 49.0 44.6
(37.1-60.9) (29.9-59.3)
Weight, percentile 60 59
(38–82) (33–86)
Height (cm) 146 141
(132–160) (127–155)
Height, Percentile 40 43
(17–63) (15–71)
BMI (kg/m2) 22.1 21.3
(18.9-25.2) (17.7-24.9)
BMI Percentile 63 69
(39–87) (48–90)
Outdoor sport activities
(h/week)
5 6
(3–6) (4–7)
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than 4000 healthy subjects of both sex and in the same
age range of the study population.
Statistical analysis
To demonstrate a difference of 25% in serum 25(OH)D
concentration between the two study groups at T1, we
estimated a sample size of 12 patients in each group in
order to obtain a power of the study of 85% (type 1
error = 0.05; two-tailed test). This computation was
based on the results of a preliminary trial (data on file).
Our estimation of sample size allowed for a drop out of
up to 20%.
Statistical analysis was performed by researchers
blinded to the type of treatment received by the two
groups of children using SPSS Version 16.0 for WindowsTable 2 Calcium and Vitamin D daily dietary intake at baselin
(T1) in the two study groups
Ca2+ intake (mg/day)
Group 1 Group 2 p
T0 507 588 0.17
(221; 93–728) (353.5; 275–844)
T1° 907.5* 925* 0.79
(217.75; 741–1591) (401; 536–1201)
° Calcium and vitamin D intake was calculated considering amount received by sup
Data are expressed as median (IQR; range).(Chicago, Ill, USA). Results are reported as means and
95% confidence interval (CI) due to parametric distribu-
tion (Kolmogorov test). The Kolmogorov-Smirnov test
was used to determine if variables were normally distrib-
uted. Non-parametric results are presented as median,
IQR and range (min-max). For continuous variables,
groups were compared using Mann–Whitney test and
Wilcoxon test. For categorical variables, the χ2 test and
Fisher’s exact test were used. The level of significance
for all statistical tests was 2-sided, p< 0.05.
Results
From December 2008 to February 2009, 184 consecutive
children were considered eligible for the study. 34 chil-
dren refused to participate, 150 subjects (male 50%,
mean age 10 years, range 9.3-10.6, BMI 18.7, 17.9-19.5)
filled the dietary questionnaire. All children were from
the Campania region. Campania region is one of the
most populated (5,834,056 residents), industrialized and
sunny region of Italy, located in the south of the Coun-
try. The families well accepted the study procedures. A
correctly filled questionnaire was provided by each par-
ent/tutor. The median (IQR; range) daily intake of Ca2+
and VitD was 744.5 mg (427.2; 93–1679) and 0.79 μg,
(1.8; 0.01-5.02) respectively.
A total of 82 children (54.6%; male 50%, mean age
10.6 years, range 9.7-11.4, BMI 18.8, 17.9-19.8) showed a
concomitant Ca2+ and VitD intake <70% of the DRIs.
The first 24 subjects observed with these characteristics
were invited to participate in the randomized trial. The
families agreed to participate, but two subjects per group
were lost at the follow-up and they were not considered
for the final statistical analysis. The comparative study
was performed from February to June 2009. The main
demographic and clinical characteristics of the two study
groups were similar (Table 1). A median of five hours
per week of outdoor sport activities during afternoon
was reported in both groups. At T0 the two groups
showed similar Ca2 + and VitD intakes (Tables 2 and 3).
The supplementation with Ca2+ and VitD was well ac-
cepted in all study subject enrolled in Group 1. The ad-
herence was optimal considering that all children
consumed >90% of the daily dose during the entire studye (T0) and after four months of nutritional intervention
VitD3 intake (μg/day)
Group 1 Group 2 p
4 1.55 1.98 0.705
(2.23; 0.03-4.3) (3.03; 0.1-3.58)
0 12.11** 2.40 <.001
(3.40; 10.3-15.79) (2.14; 0.43-5.38)
plementation with the study product. *T0 vs T1 p<0.001; ** T0 vs T1 p=0.013.
Table 3 Ca2+ and VitD3 % DRI at baseline (T0) and after four months of nutritional intervention (T1) in the two study
groups
% Ca2+ DRI % VitD3 DRI
Group 1 Group 2 p Group 1 Group 2 p
T0 42.6 60.95 0.082 15.55 19.8 0.705
(27.38; 7.75-61) (24.22; 22.91-70.33) (22.28; 0.3-43) (30.33; 1–35.8)
T1 75.62* 79.33** 0.722 121.15* 24 <.001
(29.5; 61.75-198.87) (31.15; 67–113.87) (33.98; 103–157.9) (21.4; 4.3-53.8)
*T0 vs T1 p<0.001; ** T0 vs T1 p=0.008.
Data are expressed as median (IQR; range).
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in Group 1 showed a simultaneous improvement of VitD
and Ca2+ intake. At T1 children in Group 2 showed only
a significant increase of Ca2+ intake, but not of VitD
(Table 2). Serum Ca2+ levels were similar in the two
groups at T0 and at T1. At baseline serum 25(OH)D
levels were below the optimal value (≥30 ng/ml) [16] in
both groups. After four months of nutritional interven-
tion all subjects in Group 1 and only one child in Group
2 showed serum 25 (OH) D within normal value
(Figure 1).
Discussion
In the first part of the study we investigated Ca2+ and VitD
intake in a cohort of healthy children afferent to our De-
partment because of a vaccination program. This cohort
was representative of a normal bright skin pediatric popu-
lation living in an industrialized sunny area of South Italy
where geographical alignment includes latitude of 42°-39°
North. In all subjects we observed an inadequate dietary
VitD intake, that was frequently associated (55% of cases)
with inadequate Ca2+ intake.
The determination of serum 25(OH)D level in children
enrolled in the second part of the study confirm an inad-
equate intake at baseline. The best indicator of VitD25
 (O
H)
 D
 ng
/m
L
Group 1 Group 2
p<0.001 p<0.001
Figure 1 Serum 25(OH)D levels observed at baseline (T0) and
after four months of nutritional interventions (T1) in the two
study groups.status is 25(OH)D concentration, which reflects absorp-
tion from the diet and synthesis by the skin [17]. Meas-
uring concentration of 1,25-OH2-D instead of 25(OH)D
for assessment of VitD status could be incorrect, be-
cause 1,25-OH2-D concentration could be normal or el-
evated in case of VitD deficiency as a result of secondary
hyperparathyroidism [17]. Although there is no consen-
sus on the optimal serum level of 25(OH)D, VitD insuffi-
ciency is commonly defined as 25(OH)D level between
21 to 29 ng/ml and VitD deficiency by 25(OH)D <20
ng/ml [16]. All study subjects enrolled in the second
part of the study were below this limit. Our findings are
consistent with those recently described in children liv-
ing in Northern Italy, where a high prevalence of VitD
deficiency (>50% of subjects) was observed [18].
The skin synthesis of VitD occurs during all around
the year only at latitudes between the equator (latitude
0°) and about 37° North and 37° South. Outside this area
the synthesis of VitD decreases progressively by moving
toward the poles (latitude 90°) [16,19]. The Campania
region is included in the so-called "VitD Winter zone".
Thus during the winter season skin synthesis of VitD is
generally inadequate. In fact, in winter season and at
higher latitudes, the number of ultraviolet (UV) radia-
tions reaching the Earth’s atmosphere decreases. As a
consequence, small amounts of VitD are produced by
the skin [20].
Until the 1990s the criteria for appropriate VitD intake
was the absence of overt rickets or osteomalacia [17]. Our
results support the concept that it could be wrong to as-
sume that simply because children live in a sunny area,
they need less VitD supplementation. Moreover, the Insti-
tute of Medicine (IOM) has recently revised its recom-
mendations for Dietary reference intakes (DRIs) for VitD
and calcium for US and Canadian populations. The IOM
recommended daily intakes of VitD were increased from
200 IU to 400 IU in infants (0–12 months) and from 200
IU to 600 IU in children (1–18 years) [17]. These new
DRIs support even more the results of our randomized
trial. Despite the small sample size and problems deriving
from a non-standardized nutritional guidelines, our results
show that simple dietary counseling is insufficient to
normalize VitD intake and 25(OH)D levels.
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Studies suggest that VitD insufficiency is a global public
health problem across all life stages with serious short
and long-term clinical consequences [4,21]. According
to our findings, a dietary counseling alone is unable to
obtain an adequate VitD intake that is necessary for
body health and to reach optimal 25(OH)D serum levels.
Unfortunately, the high prevalence of insufficient VitD
dietary intake is largely unknown among clinicians and
patients. We feel that long term strategies to address this
silent disease should include public education and health
policies for prevention, through food fortification and
VitD supplementation.
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